Irvine, CA
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharmaโs dasiglucagon, a glucagon analogue with a stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community.
betabionics.comThese are collections Beta Bionics is a part of. Click on the collection name to view similar companies.
IPO
Unknown
Series E
$60,000,000
Series D
$100,000,000
Series C
$57,000,000
Series B
$63,000,000
Series B
$63,000,000
Grant
$2,000,000
Series Unknown
$2,452,916
Equity Crowdfunding
$1,000,000
Series A
$5,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Beta Bionics.